BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) to report its financial ...
The new drug application (NDA) (the "Application") based on the positive results from the pivotal phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) ...
We identified different transcriptomic states of the endocrine syncytiotrophoblast nuclei with patterns of dysregulation associated with a senescence-associated secretory phenotype and a spatial ...
TROPiCS-03 is a basket study designed to evaluate the efficacy and safety of sacituzumab govitecan, a trophoblast cell-surface antigen 2–directed ADC, in patients with metastatic solid tumors.
Menopause usually begins between 45 and 55 years of age, but some people may experience it as early as age 35. This is known as early menopause. Treatments for symptoms include supplements and ...
Here, we developed matched trophoblast (TO) and decidua organoids (DO) from human placentas to define the relative contributions of these cells to antiviral defenses at the maternal-fetal interface.
Zika virus (ZIKV) can be transmitted from mother to fetus during pregnancy, causing adverse fetal outcomes. Several studies have indicated that ZIKV can damage the fetal brain directly; however, ...